Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-19

Clinical Trial Update: Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load

View source ↗

Summary

The formative phase of a trial examining interventions to reduce hazardous alcohol use and improve HIV viral load among ART patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Drinking, Alcohol Use Norms | Status: COMPLETED